Merck to take $10.3 billion R&D charge for Prometheus deal t

Merck & Co expects a research-and-development charge of about $10.3 billion, or $4 per share, this year as the drugmaker accounts its deal for Prometheus Biosciences Inc as an asset... | April 17, 2023

Related Keywords

Bengaluru , Karnataka , India , Raghav Mahobe , Devika Syammnath , Leroy Leo , , Prometheus Biosciences , Nc Stock Exchange , News , Information , Press Release , Merck , O , Xpects , Charge , F , Bout , Dr , Her , This , Ear , Us , The , Drugmaker , Accounts , Its , Meal , Or , Prometheus , Iosciences , Nc , N Rxdx Us74349u1088 ,